PL377557A1 - Zastosowanie rezweratrolu do otrzymywania leku użytecznego w leczeniu infekcji wywołanej wirusem grypy - Google Patents

Zastosowanie rezweratrolu do otrzymywania leku użytecznego w leczeniu infekcji wywołanej wirusem grypy

Info

Publication number
PL377557A1
PL377557A1 PL377557A PL37755703A PL377557A1 PL 377557 A1 PL377557 A1 PL 377557A1 PL 377557 A PL377557 A PL 377557A PL 37755703 A PL37755703 A PL 37755703A PL 377557 A1 PL377557 A1 PL 377557A1
Authority
PL
Poland
Prior art keywords
resveratrol
preparation
treatment
influenza virus
virus infections
Prior art date
Application number
PL377557A
Other languages
English (en)
Other versions
PL217628B1 (pl
Inventor
Enrico Garaci
Anna Teresa Palamara
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL377557A1 publication Critical patent/PL377557A1/pl
Publication of PL217628B1 publication Critical patent/PL217628B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL377557A 2002-11-06 2003-10-14 Zastosowanie resweratrolu do wytwarzania leku wywierającego działanie inhibitorowe na replikację wirusa grypy do zapobiegania i/lub leczenia infekcji wywołanej wirusem grypy PL217628B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.

Publications (2)

Publication Number Publication Date
PL377557A1 true PL377557A1 (pl) 2006-02-06
PL217628B1 PL217628B1 (pl) 2014-08-29

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377557A PL217628B1 (pl) 2002-11-06 2003-10-14 Zastosowanie resweratrolu do wytwarzania leku wywierającego działanie inhibitorowe na replikację wirusa grypy do zapobiegania i/lub leczenia infekcji wywołanej wirusem grypy

Country Status (18)

Country Link
US (1) US8431617B2 (pl)
EP (1) EP1567137B1 (pl)
JP (1) JP4589118B2 (pl)
KR (1) KR101060331B1 (pl)
AR (1) AR041891A1 (pl)
AT (1) ATE381929T1 (pl)
AU (1) AU2003279551A1 (pl)
CA (1) CA2504872C (pl)
CY (1) CY1107302T1 (pl)
DE (1) DE60318327T2 (pl)
DK (1) DK1567137T3 (pl)
ES (1) ES2295660T3 (pl)
IT (1) ITRM20020562A1 (pl)
MX (1) MXPA05004628A (pl)
PL (1) PL217628B1 (pl)
PT (1) PT1567137E (pl)
TW (1) TWI337863B (pl)
WO (1) WO2004041260A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260690A1 (en) * 2005-11-18 2008-10-23 Ares Trading S.A. Interferon in Influenza
CA2717119A1 (en) * 2008-03-06 2009-11-12 Mount Sinai School Of Medicine Of New York University Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
US20100112099A1 (en) * 2008-11-04 2010-05-06 Metaproteomics, Llc Phytochemical compositions and methods for activating amp-kinase
EP2373329A4 (en) * 2008-12-19 2012-07-04 Univ California USE OF INGREDIENTS OF THE EPIDERMAL GROWTH FACTOR IN THE TREATMENT OF VIRUS INFECTIONS
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
WO2011150413A1 (en) 2010-05-28 2011-12-01 Mount Sinai School Of Medicine Antiviral compounds and uses thereof
CA2850597A1 (en) * 2011-09-30 2013-04-04 Vanderbilt University Antiviral therapies with phospholipase d inhibitors
EP2952180B1 (en) 2014-06-04 2017-01-25 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Solid formulations containing resveratrol and omega-3 polyunsaturated fatty acids (n-3 PUFA)
PL2952209T3 (pl) 2014-06-04 2018-07-31 Alfasigma S P A Jednorodne formulacje zawierające wielonienasycone kwasy tłuszczowe omega-3 (n-3 PUFA) i resweratrol do podawania doustnego
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
WO2021207094A1 (en) * 2020-04-05 2021-10-14 Mong Michael Systems and methods for treating coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
US6479466B1 (en) * 1999-08-13 2002-11-12 University Of Maryland Compositions for treating viral infections, and methods therefor

Also Published As

Publication number Publication date
WO2004041260A1 (en) 2004-05-21
AU2003279551A1 (en) 2004-06-07
CY1107302T1 (el) 2012-11-21
ES2295660T3 (es) 2008-04-16
KR101060331B1 (ko) 2011-08-30
DK1567137T3 (da) 2008-04-28
KR20050071627A (ko) 2005-07-07
US20050239906A1 (en) 2005-10-27
TWI337863B (en) 2011-03-01
DE60318327T2 (de) 2008-12-18
DE60318327D1 (de) 2008-02-07
CA2504872A1 (en) 2004-05-21
EP1567137B1 (en) 2007-12-26
TW200501935A (en) 2005-01-16
CA2504872C (en) 2011-07-05
ITRM20020562A1 (it) 2004-05-07
JP2006507295A (ja) 2006-03-02
EP1567137A1 (en) 2005-08-31
PL217628B1 (pl) 2014-08-29
ATE381929T1 (de) 2008-01-15
AR041891A1 (es) 2005-06-01
US8431617B2 (en) 2013-04-30
MXPA05004628A (es) 2005-09-08
JP4589118B2 (ja) 2010-12-01
PT1567137E (pt) 2008-02-19

Similar Documents

Publication Publication Date Title
HK1087337A1 (en) Use of a hif-alpha stabilizing agent for the preparation of medicament for treatment of diabetes
EP1603590A4 (en) INFLUENZA VIRUS VACCINE
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2002310325A1 (en) Use of ozone for the prevention of infection caused by medical devices
ZA200410229B (en) Administration of therapeutic viruses
CY2014019I1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
EP1594512A4 (en) COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
IL182105A0 (en) Use of memantine for the preparation of a medicament for the treatment of childhood behavioral disorders
PL376454A1 (pl) Pochodne 1-acylo-pirolidynowe do leczenia zakażeńwirusowych
PL377557A1 (pl) Zastosowanie rezweratrolu do otrzymywania leku użytecznego w leczeniu infekcji wywołanej wirusem grypy
IL167187A (en) Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament
HK1095036A1 (en) Virus therapeutic drug
AUPR553701A0 (en) A device for the delivery of a drug to a fractured bone
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
BRPI0215039A2 (pt) processo para a preparação de uma vacina de antraz não-tóxica
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AU2001278337A1 (en) Respiratory syncytial virus vaccine
SI1567137T1 (sl) Uporaba resveratrola za pripravo zdravila za uporabo pri zdravljenju infekcij z virusom influence
AU1039601A (en) Medicaments for treatment of respiratory syncytial virus infections
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
GB0212790D0 (en) Medicament for the treatment of diabetes
AU2002325312A1 (en) Use of certain castanospermine esters in the treatment of influenza virus infections